Company: BIAF
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001641172-25-010787
Chunk: 61

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 8
Chunk 61
---
     1,600,000  
     1.64  
     (1,066,667) 
     533,333 
  
    Placement agent direct offering March 8, 2024 
     32,000  
     1.64  
     —  
     32,000 
  
    Inducement/direct offering August 5, 2024 
     1,752,082  
     1.50  
     (1,302,082) 
     450,000 
  
    Placement agent direct offering August 5, 2024 
     49,862  
     1.50  
     —  
     49,862 
  
    Direct offering October 21, 2024 
     2,662,782  
     1.50  
     (1,136,391) 
     1,526,391 
  
    Placement agent direct offering October 21, 2024 
     61,448  
     1.50  
     —  
     61,448 
  
    Warrant inducement February 25, 2025 
     2,926,166  
     0.85  
     —  
     2.926.166 
  
    Placement agent warrant inducement February 25, 2025 
     87,785  
     0.85  
     —  
     87,785 
  
    Balance at March 31, 2025 
     17,415,328  
    $2.74  
     (4,541,726) 
     12,873,602 

Note 15. SUBSEQUENT EVENTS

On May 7, 2025, the Company
completed a public offering of securities for gross proceeds to the Company of $3.25
million, before deducting placement agent fees and other estimated expenses payable by the company. The offering consisted of 10,156,250
shares of our Common Stock, of which 2,371,346
were pre-funded warrants, together with warrants to initially purchase up to 15,234,375
shares of Common Stock, at a combined offering price for each share of common stock (or pre-funded warrant) and accompanying warrant
of $0.32
per share.